NWHFC logo

Welcome to the NWHFC Project ECHO Webinar Archive

This is the archive of all recorded didactic sessions from previous webinars. These webinar videos are free to view on the Northwest Heart Failure Collaborative Project ECHO YouTube Channel.

Participants at the IPE meeting in Bogota, Colombia in December 2016.

1. Heart Failure: Identifying the Syndrome and Burden of Disease

Watch Video

More information

Date: May 4, 2016
Speaker: Todd Dardas, MD, MS
Panelists: Alice Chang, MSW; Tracy Fowler, ARNP; Todd Dardas, MD, MS
Facilitators: Brenda Zierler, PhD, RN, FAAN and John Scott, MD, MSc

Learning Objectives:
1. Define factors that contribute to prevalence of heart failure.
2. Identify modifiable risk factors that are most responsible for reducing prevalence of heart failure.
3. Discuss the Framingham and the Cardiovascular Health Study criteria for heart failure.

Participants at the IPE meeting in Bogota, Colombia in December 2016.

2. Staging and Prognosis of Heart Failure

Watch Video

More information

Date: May 18, 2016
Speaker: Jennifer Beckman, MSN, ARNP, CHFN
Panelists: Alice Chang, MSW; Claudius Mahr, DO, FACC, FESCJennifer Beckman, MSN, ARNP, CHFN
Facilitators: Brenda Zierler, PhD, RN, FAAN); and Todd Dardas, MD, MS

Learning Objectives:
1. Describe the stages of heart failure according to the ACC/AHA criteria.
2. Differentiate between the stages of heart failure and the functional classes of heart failure.
3. Identify patients with advanced heart failure and when to refer for advanced treatment options.

Participants at the IPE meeting in Bogota, Colombia in December 2016.

3. Diuretics and Decongestion

Watch Video

More information

Date: June 1, 2016
Speaker: Kevin O’Brien, MD, FAHA
Panelists: Alice Chang, MSW; Greg Gipson, PharmD; Kevin O’Brien, MD, FAHA; Tracy Fowler, ARNP
Facilitators: Brenda Zierler, PhD, RN, FAAN, and Todd Dardas, MD, MS

Learning Objectives:
1. Describe why patients with heart failure (HF) can have large differences in central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP).
2. Demonstrate a practical method for assessing jugular venous pressure (JVP) by physical exam in HF patients.
3. Use an algorithm for IV diuretic escalation in patients hospitalized with acute decompensated heart failure (ADHF).

Participants at the IPE meeting in Bogota, Colombia in December 2016.

4. ACE-Inhibitors and Other Vasodilators

Watch Video

More information

Date: June 15, 2016
Speaker: Todd Dardas, MD, MS
Panelists: Alice Chang, MSW; Greg Gipson, PharmD; Todd Dardas, MD, MS; Carrie Boom, ARNP
Facilitators: Brenda Zierler, PhD, RN, FAAN and Kevin O’Brien, MD, FAHA

Learning Objectives:
1. Identify an angiotensin converting enzyme-inhibitor for use in Stage B heart failure.
2. Manage complications associated with ACE-inhibitor.
3. Explain arguments for and against dose escalation of ACE-inhibitors.

Participants at the IPE meeting in Bogota, Colombia in December 2016.

5. Clinical Applications of Beta Blocker Therapy

Watch Video

More information

Date: July 6, 2016
Speaker: Claudius Mahr, DO, FACC, FESC
Panelists: Claudius Mahr, DO, FACC, FESC; Jason Tran, MSW; Jennifer Beckman, MSN, ARNP, CHFN; Liz Brule, PharmD, BCPS
Facilitators: Brenda Zierler, PhD, RN, FAAN and Todd Dardas, MD, MS

Learning Objectives:
1. Select an appropriate beta-blocker for use in Stage B-D heart failure.
2. Provide goal-directed medical therapy for heart failure.
3. Understand evidence gaps and clinical trial limitations.
4. Identify clinical inflection points in the heart failure trajectory.

Participants at the IPE meeting in Bogota, Colombia in December 2016.

6. Aldosterone Receptor Inhibitors: Effective and Forgotten

Watch Video

More information

Date: July 20, 2016
Speaker: Todd Dardas, MD, MS
Panelists: Alice Chang, MSW; Heidi Kresken, ARNP; Liz Brule, PharmD, BCPS
Facilitator: Todd Dardas, MD, MS

Learning Objectives:
1. Understand the effectiveness of aldosterone receptor blocking medications in stage B-D heart failure.
2. Identify potential complications and adverse effects of aldosterone receptor blockade.
3. Discuss how to safely start ARB.

Participants at the IPE meeting in Bogota, Colombia in December 2016.

7. Putting it Together: Pharmacology

Watch Video

More information

Date: August 3, 2016
Speaker: Kevin O’Brien, MD, FAHA
Panelists: Carrie Boom, ARNP; Greg Gipson, PharmD, BCPS; Jason Tran, MSW; Kevin O’Brien, MD, FAHA; Sharon Whyte, RN
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Understand the role of sacubitril/valsartan in HFrEF based on new guideline recommendations.
  2. Plan dose initiation and dose titration for beta-blockers, ACE-I/ARB, spironolactone and sacubitril/valsartan.
  3. Address issues of polypharmacy and cost with patients.
  4. Identify common interactions between HF medications.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

8. Internal Cardioverter Defibrillators: Issues of Over and Underutilization

Watch Video

More information

Date: August 17, 2016
Speaker: Todd Dardas, MD, MS
Panelists: Alice Chang, MSW; Linda Marriott, ARNP; Andra Miura, PharmD
Facilitator: Todd Dardas, MD, MS
 
Learning Objectives:

  1. Understand the minimum criteria for ICD implant for Secondary Prevention.
  2. Understand the role of symptoms in ICD implant determina.
  3. Be familiar with Department of Justice efforts to assure appropriateness and the role of the heart failure provider in this setting.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

9.Cardiac Resynchronization Therapy: How Does it Work & for Whom?

Watch Video

More information

Date: September 7, 2016
Speaker: Nazem Akoum, MD, MS
Panelists: Alice Chang, MSW; Susan Pambianco, ARNP; Jenny Wong, PharmD; Nazem Akoum, MD, MS
Facilitator: Kevin O’Brien, MD, FAHA

Learning Objectives:

  1. Understand the role of electrical dys-synchrony in systolic heart failure
  2. Identify which patients are candidate for cardiac re-synchronization therapy (CRT)
Participants at the IPE meeting in Bogota, Colombia in December 2016.

10. Depression in Heart Failure (Part 1)

Watch Video

More information

Date: September 21, 2016
Speaker: Jean Tang, PhD, PMHNP-BC, APRN
Panelists: Todd Ray, ARNP; Alice Chang, MSW; Kevin O’Brien, MD, FAHA
Facilitators: Brenda Zierler, PhD, RN, FAAN and Kevin O’Brien, MD, FAHA

 

Learning Objectives:

  1. Describe shared symptoms between depression and Heart Failure (HF).
  2. Recognize risk factors for comorbid depression and HF.
  3. Identify common clinical tools for assessing depression.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

11. The Hidden Issues and Challenges to Managing Heart Failure Patients

Watch Video

More information

Date: October 5, 2016
Speaker: Alice Chang, MSW
Panelists: Alice Chang, MSW; Greg Gipson, PharmD; and Heidi Kresken, ARNP
Facilitator: Todd Dardas, MD, MS
 
Learning Objectives:

  1. Identify psychosocial factors related to care planning and management of heart failure patients.
  2. Describe SIPAT (Stanford Integrated Psychosocial Assessment for Transplantation) and the usefulness in clinical practice.
  3. Discuss how psychosocial interventions improve chances for adherence and successful outcome.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

12. Implicit Bias in Healthcare

Watch Video

More information

Date: October 19, 2016
Speaker: Janice Sabin, PhD, MSW
Panelists: Alice Chang, MSW; Greg Gipson, PharmD; Janice Sabin, PhD, MSW; Susan Pambianco, ARNP
Facilitators: Todd Dardas, MD, MS

Learning Objectives:

  1. Define implicit bias
  2. Recognize how implicit bias may be operating in the clinical setting.
  3. Apply strategies to minimize impact of implicit bias.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

13. Transitions in Care: Discharging a Patient and the Medication Reconciliation Process

Watch Video

More information

Date: November 2, 2016
Speaker: Beatrice Wong, PharmD, BCPS
Panelists: Alice Chang, MSW; Susan Pambianco, ARNP; Beatrice Wong, PharmD, BCPS
Facilitators: Brenda Zierler, PhD, RN, FAAN and Todd Dardas, MD, MS

Learning Objectives:

  1. Identify 3 risk factors that can increase the likelihood of hospital readmission in patients with heart failure.
  2. Describe examples of best practice models for transitions of care and medication reconciliation, involving the interprofessional team and patient/family/caregivers.
  3. Discuss specific evidence-based recommendations for the discharge process in clinical practice.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

14. Approach to Atrial Fibrillation in Hearth Failure with Reduced Ejection Fraction

Watch Video

More information

Date: November 16, 2016
Speaker: Jordan Prutkin, MD, MHS
Panelists: Alice Chang, MSW; Jennifer Beckman, MSN, ARNP, CHFN; Todd Dardas, MD, MS; Andrea Miura, PharmD, BCPS
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Assess impact of atrial fibrillation on HFREF.
  2. Apply anticoagulation management.
  3. Identify when to use rate and rhythm management options.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

15. Left Ventricular Assist Devices: When to Consider and What to Expect?

Watch Video

More information

Date: December 7, 2016
Speaker: Claudius Mahr, DO, FACC, FESC
Panelists: Alice Chang, MSW; Jennifer Beckman, MSN, ARNP, CHFN; Claudius Mahr, DO, FACC, FESC; Lynda Tanagi, PharmD
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Describe risk stratification in advanced heart failure.
  2. Identify clinical features portending poor prognosis.
  3. Recognize indications for Ventricular Assist Device (VAD) therapy.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

16. Impact of Diabetes in Heart Failure

Watch Video

More information

Date: January 4, 2017
Speaker: Kevin O’Brien, MD, FAHA
Panelists: Alice Chang, MSW; Jennifer Beckman, MSN, ARNP, CHFN; Todd Dardas, MD, MS; Liz Brule, PharmD, BCPS
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Understand the relationship of diabetes and its complications to increased risk for HF.
  2. Understand the relationships of intensive insulin therapy in decreasing HF risk in patients with diabetes.
  3. Describe the relationships of other glucose-lowering approaches to HF risk in patients with diabetes.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

17. Remote Pulmonary Pressure Monitoring

Watch Video

More information

Date: January 18, 2017
Speaker: Todd Dardas, MD, MS
Panelists: Susan Pambianco, ARNP; Todd Dardas, MD, MS; Alice Chang, MSW; Liz Brule, PharmD, BCPS
Facilitator: Brenda Zierler, PhD, RN, FAAN

Learning Objectives:

  1. Describe the function of the CardioMems system.
  2. Understand the CHAMPION trial results.
  3. Review the cost-effectiveness of the CardioMems system.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

18. Telehealth in the Home

Watch Video

More information

Date: February 2, 2017
Speaker: George Demiris PhD, FACMI
Panelists: Jennifer Beckman, MSN, ARNP, CHFN; Todd Dardas, MD, MS; Alice Chang, MSW; Susan Cho, PharmD; George Demiris, PhD, FACMI
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Provide an overview of the current status and potential of tele health in supporting home based symptom management.
  2. Synthesize current evidence of the effectiveness of tele health in the home and  explore future opportunities.
  3. Examine ethical, technical and clinical challenges associated with the use of tele health in the home.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

19. The Role of the Kidney in Heart Failure

Watch Video

More information

Date: March 15, 2017
Speaker: Todd Dardas, MD, MS
Panelists: Jennifer Beckman, MSN, ARNP, CHFN; Todd Dardas, MD, MS; Alice Chang, MSW; Greg Gipson, PharmD
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Understand different mechanisms of renal dysfunction in heart failure.
  2. Discuss the trade offs between medical therapy and renal dysfunction.
  3. Design an approach to addressing renal dysfunction in heart failure.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

20. Heart Failure Transition of Care Programs

Watch Video

More information

Date: April 5, 2017
Speaker: Hilary Law, MN, RN, CHFN
Panelists: Margie Concepcion, ARNP; Alice Chang, MSW; Greg Gipson, PharmD
Facilitator: Erin Blakeney, PhD, RN

Learning Objectives:

  1. Recognize the importance of transition of care programs.
  2. Identify features of transition of care programs from hospital to community.
  3. Apply knowledge of resources to support transition of care.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

21. Preventing Heart Failure Admissions: Invasive Hemodynamic Monitoring

Watch Video

More information

Date: April 19, 2017
Speaker: Gregory Wood, MD, MS
Panelists: Todd Ray, ARNP; Kevin O’Brien, MD, FAHA; Alice Chang (MSW); Beatrice Wong, PharmD, BCPS
Facilitator: Kevin O’Brien, MD, FAHA

Learning Objectives:

  1. Review indications for CardioMEMS implantation.
  2. Understand basic principles for medication adjustment when managing a patient by PA pressure.
  3. Describe the phases of management of a CardioMEMS patient.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

22. Detecting and Evaluating Cognitive Impairment in Heart Failure Patients

Watch Video

More information

Date: May 3, 2017
Speaker: Tatiana Sadak, PhD, PMHNP, ARNP
Panelists: Mariah Martin, ARNP; Alice Chang, MSW; Liz Brule, PharmD, BCPS; Todd Dardas, MD, MS
Facilitators: Todd Dardas, MD, MS

Learning Objectives:

  1. Describe the prevalence and patterns of cognitive impairment in heart failure patients.
  2. Know what instruments are used to screen for cognitive impairment.
  3. Access information about administering Mini-CogTM, Montreal Cognitive Assessment, and AD 8 screens.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

23. Ethics of Heart Failure Management

Watch Video

More information

Date: May 17, 2017
Speaker: James Kirkpatrick, MD, FASE, FACC
Panelists: Alice Chang, MSW; Lynda Tanagi, PharmD; Todd Dardas, MD, MS; Sharon Whyte, ARNP
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Define “shared decision-making.”
  2. Identify 5 ethical foundations of choices in heart failure.
  3. Discuss important considerations in rationing and futility.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

24. Diastolic Heart Failure Review & State-of-the-Art

Watch Video

More information

Date: June 7, 2017
Speaker: Todd Dardas, MD, MS
Panelists: Alice Chang, MSW; Heidi Kresken, ARNP; Jenny Wong, PharmD; Todd Dardas, MD, MS
Facilitator: Todd Dardas, MD, MS

Participants at the IPE meeting in Bogota, Colombia in December 2016.

25. Intersections of Palliative Care and Advanced Heart Failure

Watch Video

More information

Date: June 21, 2017
Speaker: James Fausto, MD
Panelists: Alice Chang, MSW; Beatrice Wong, PharmD; Kevin O’Brien, MD, FAHA; Susan Pambianco, ARNP
Facilitator: Kevin O’Brien, MD, FAHA

Learning Objectives:

  1. Define palliative care.
  2. Summarize current needs for palliative care in end stage heart failure.
  3. Review palliative treatment options of dyspnea in end stage heart failure.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

26. International Society of Heart & Lung Transplant 2017 Annual Meeting: Updates on Ventricular Assist Devices

Watch Video

More information

Date: July 5, 2017
Speaker: Shin Lin, MD
Panelists: Alice Chang, MSW; Andrea Miura, PharmD; Claudius Mahr, DO, FACC, FESC; Jennifer Beckman, MSN, ARNP, CHFN
Facilitator: Claudius Mahr, DO, FACC, FESC

Learning Objectives:

  1. Describe the two basic types of left ventricular assist devices (LVAD) in use.  
  2. List agents expected to be in a VAD patient’s medical regimen.
  3. Describe risk factors leading to a poorer outcome for VAD patients.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

27. Adherence and Medications to Avoid in Heart Failure

Watch Video

More information

Date: September 6, 2017
Speaker:  Jennifer Beckman, MSN, ARNP, CHFN
Panelists: Alice Chang, MSW;  Jennifer Beckman, MSN, ARNP, CHFN; Greg Gipson, PharmD
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Review general principles related to medication avoidance specific to the heart failure (HF) population.
  2. Discuss specific drug classes to avoid.
  3. Review goals of medication adherence.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

28. Patient-Reported Outcome Measures: Implications for Engaging Patients with Advanced Heart Failure

Watch Video

More information

Date: September 20, 2017
Speaker:  Danielle Lavallee, PharmD, PhD
Panelists: Alice Chang, MSW; Andrea Miura, PharmD; Kevin O’Brien, MD, FAHA; Susan Pambianco, ARNP
Facilitator: Kevin O’Brien, MD, FAHA

Learning Objectives:

  1. Define Patient-Reported Outcomes (PROs).
  2. Discuss efforts promoting the implementation of PROs in health care.
  3. Describe how PRO data supports patient engagement.
  4. Identify challenges and future opportunities for PRO implementation in clinical settings.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

29. Heart Failure in Adult Congenital Heart Disease: Differences and Similarities Compared to Heart Failure in Acquired Heart Disease

Watch Video

More information

Date: October 4, 2017
Speaker: Karen Stout, MD
Panelists: Alice Chang, MSW; Mariah Martin, ARNP; Todd Dardas, MD, MS; and Susan Rowe, PharmD
Facilitator: 
Todd Dardas, MD, MS

Learning Objectives:

  1. Review the increasing prevalence of Adult Congenital Heart Disease (ACHD) and associated long-term complications.
  2. Identify unique aspects of Heart Failure (HF) in ACHD and the impacts on treatment.
  3. Summarize the conditions for when referral to an ACHD specialty center is appropriate.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

30. Increasing Participation in Cardiac Rehabilitation

Watch Video

More information

Date: October 18, 2017
Speaker:  Alexis Beatty, MD, MAS
Panelists: Alice Chang, MSW; Mariah Martin, ARNP; and Todd Dardas, MD, MS
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Describe the core components of cardiac rehabilitation.
  2. Apply inclusion/exclusion criteria for referring patients to cardiac rehabilitation.
  3. Assess barriers/facilitators to attending cardiac rehabilitation.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

31. Navigating the Heart Failure Discharge

Watch Video

More information

Date: November 1, 2017
Speaker:  Susan Pambianco, ARNP
Panelists: Alice Chang, MSW;  Jennifer Beckman, MSN, ARNP, CHFN; Elena Meeker, PharmD
Facilitator: N/A

Learning Objectives:

  1. Review the importance of safely discharging patients from the hospital.
  2. Describe evidence based on guidelines and recommendations for safe transitions of care.
  3. Identify opportunities for implementation of the guidelines into practice.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

32. Substance Use Disorders

Watch Video

More information

Date: November 15, 2017
Speaker:  Ron Jackson, MSW, LICSW 
Panelists: Jason Tran, MSW; Susan Pambianco, ARNP; and Mina Lee, PharmD
Facilitator: N/A

Learning Objectives:

  1. Explain why substance use disorder (addiction) is considered a chronic medical condition with genetic, environmental, and behavioral factors.
  2. Review key criteria included in the formal diagnosis for substance use disorder.
  3. Name a resource for where to find information on substance use disorder and local treatment services.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

33. Ischemia Evaluation for Patients with Reduced Systolic Function

Watch Video

More information

Date: December 6, 2017
Speaker: Todd Dardas, MD, MS
Panelists: Susan Pambianco, ARNP; Todd Dardas, MD, MS; Alice Chang, MSW; Marianne Weber, PharmD
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Choose a stress study for evaluation of ischemia in persons with low ejection fraction (EF).
  2. Identify when to obtain a viability study in low EF.
  3. Determine when to revascularize CAD for low EF.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

34. Echo Trends

Watch Video

More information

Date: December 20, 2017
Speaker: James N. Kirkpatrick, MD, FASE, FACC     
Panelists: Susan Pambianco, ARNP; Todd Dardas, MD, MS; Alice Chang, MSW     
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Describe two reasons for using quantitative assessment of left ventricular systolic function.
  2. Identify 2 indications for using measures other than LVEF to assess systolic function.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

35. Cardiopulmonary Exercise Testing

Watch Video

More information

Date: January 3, 2018
Speaker:  Laurie Soine, PhD, ARNP
Panelists: Alice Chang, MSW; Susan Pambianco, ARNP
Facilitator:  Susan Pambianco, ARNP

Learning Objectives:

  1. Recognize the patient that would benefit from formal CPET.
  2. Describe the CPET procedure.
  3. Identify high risk CPET study findings.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

36. Advances in Heart Transplant: Ex-Vivo Heart Perfusion

Watch Video

More information

Date: January 17, 2018
Speaker: Jason Smith, MD, FACS
Panelists: Susan Pambianco, ARNP; Alice Chang, MSW
Facilitator: N/A

Learning Objectives:

  1. Review the limitations of cold storage for preservation of heart allograft.
  2. Assess the potential benefits of ex-vivo perfusion of organs for transplantation.
  3. Interpret study data available for ex-vivo heart perfusion.
  4. Describe the EXPAND-Heart Trial inclusion and exclusion criteria.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

37. Sleep Apnea and Cardiovascular Disorders

Watch Video

More information

Date: February 7, 2018
Speaker:  Sina Gharib, MD
Panelists: Susan Pambianco, ARNP; Alice Chang, MSW; Todd Dardas, MD, MS
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Describe the pathophysiological consequences of sleep apnea.
  2. Appreciate the association of sleep apnea with poor cardiovascular outcomes.
  3. Evaluate sleep apnea in patients with heart failure.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

38. Stress in a Deer Hunter: A Takotsubo Tale

Watch Video

More information

Date: January 21, 2018
Speaker: Gautam Nayak, MD, FACC, FACP
Panelists: Susan Pambianco, ARNP; Alice Chang, MSW; Kevin O’Brien, MD, FAHA
Facilitator: Kevin O’Brien, MD, FAHA

Learning Objectives:

  1. Describe the clinical predictors and diagnosis of stress-induced (Takotsubo) cardiomyopathy.
  2. Summarize the presenting clinical variables of stress-induced cardiomyopathy and how these variables affect acute management.
  3. Analyze the epidemiologic data guiding prognosis in stress-induced cardiomyopathy.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

39. Heart Failure Fundamentals: Physiology

Watch Video

More information

Date: March 7, 2018
Speaker: April Stempien-Otero, MD, FACC
Panelists: Susan Pambianco, ARNP; Alice Chang, MSW; April Stempien-Otero, MD, FACC
Facilitator:  Susan Pambianco, ARNP

Learning Objectives:

  1. Discuss the role injury plays in initiating heart failure.
  2. Describe the effect of systemic hormonal activation on heart failure progression.
  3. Summarize the cellular changes that occur in a failing heart.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

40. Climbing the Heart Failure Medication Ladder

Watch Video

More information

Date: March 21, 2018
Speaker:  Todd Dardas, MD, MS
Panelists:  Susan Pambianco, ARNP; Alice Chang, MSW; Marianne Web, PharmD; Todd Dardas, MD, MS
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Recognize the importance of adding heart failure medication in a stepwise fashion.
  2. Discuss the role of ARNI medication use in heart failure.
  3. Summarize the importance of safety checks when escalating heart failure medication.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

41. A Brief History of Heart Failure: Part 1

Watch Video

More information

Date:  April 4, 2018
Speaker: Amitoj Marwaha, MD
Panelists: Susan Pambianco, ARNP; Alice Chang, MSW; Marianne Web, PharmD; Todd Dardas, MD, MS
Facilitator:  Todd Dardas, MD, MS

Learning Objectives:

  1. Review some of the prior treatments for heart failure.
  2. Discuss the energy starved heart theory.
  3. Describe the implications of the energy starved heart theory on heart failure treatment.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

42. Door to Support: Cardiogenic Shock Management

Watch Video

More information

Date: April 18, 2018
Speaker:  Kevin O’Brien, MD, FAHA
Panelists: Susan Pambianco, ARNP; Alice Chang, MSW; Kevin O’Brien, MD, FAHA
Facilitator: Kevin O’Brien, MD, FAHA

Learning Objectives:

  1. Recognize the early symptoms of cardiogenic shock.
  2. Discuss the importance of initiating early intervention with a mechanical device.
  3. Review parameters for choosing an appropriate device, assessing device effectiveness, and making the decision to wean support.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

43. Integrating Sub-Specialties: Cardio-Oncology

Watch Video

More information

Date: May 2, 2018
Speaker:  Richard K. Cheng, MD, MSc, FACC
Panelists:  Susan Pambianco, ARNP; Alice Chang, MSW; Amy Indorf, PharmD; Todd Dardas, MD, MS
Facilitator: Todd Dardas, MD, MS

Learning Objectives:

  1. Define the risk of cardiovascular complications in cancer survivors.
  2. Explain key differences between anthracycline and trastuzumab cardiotoxicity.
  3. Provide a framework to manage cancer-related cardiac dysfunction.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

44. Improving Heart Failure Outcomes: A Specialized Science

Watch Video

More information

Date:  May 16, 2018
Speaker: Maghee Disch, MSN, RN, CNL, CHFN, AACC
Panelists: Panelists:  Susan Pambianco, ARNP; Alice Chang, MSW; Todd Dardas, MD, MS
Facilitator:  Todd Dardas, MD, MS

Learning Objectives:

  1. Review the current state of heart failure (HF) as an increasing burden economically and its relation to process of care.
  2. List outcomes related to improved patient care and their relevance to process.
  3. Summarize clinical care pathways, assessment and treatment of HF throughout the care continuum.
  4. Discuss transitions of care and processes to assist in success of outpatient services.
  5. Summarize current barriers to providing guideline driven medical therapy and science implementation.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

45. Stress Myocardial Perfusion Studies

Watch Video

More information

Date:  June 6, 2018
Speaker: Laurie A Soine PhD, ARNP
Panelists: Panelists:  Susan Pambianco, ARNP; Alice Chang, MSW
Facilitator: Susan Pambianco, ARNP

Learning Objectives:

  1. Recognize the patient that would benefit from stress myocardial perfusion studies.
  2. Describe the stress myocardial perfusion procedure.
  3. Summarize the four standard findings of all stress perfusion studies.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

46. Nutrition in Heart Failure: What are the real concerns?

Watch Video

More information

Date: June 20, 2018
Speaker:  Kay Kolahi RD, CD
Panelists:  Susan Pambianco, ARNP; Alisha Peterson (BSN)
Facilitator: Susan Pambianco, ARNP

Learning Objectives:

  1. Recognize the patient that would benefit from stress myocardial perfusion studies.
  2. Describe the stress myocardial perfusion procedure.
  3. Summarize the four standard findings of all stress perfusion studies.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

49. Public Reporting of Heart Failure Outcomes

Watch Video

More information

Date: October 17, 2018
Speaker:  Todd Dardas, MD, MS
Panelists:  Megan Miller, MEd, MPH; Alice Chang, MSW
Facilitator: Megan Miller, MEd, MPH

Participants at the IPE meeting in Bogota, Colombia in December 2016.

47. Cardiovascular Outcomes with Novel Hypoglycemics

Watch Video

More information

Date: September 5, 2018
Speaker:  Kevin O’Brien, MD, FAHA
Panelists:  Susan Pambianco, ARNP; Alice Chang, MSW
Facilitator: Susan Pambianco, ARNP

Content Outline:

  • Epidemiologic Association of Type 2 diabetes (T2DM) with Heart Failure (HF)
  • Mechanisms for Diabetes-induced Cardiomyopathy
  • Lack of Benefit of Intensive Insulin Therapy in HF Outcomes
  • Novel Hypoglycemics and Heart Failure:
    • Mechanisms of Action
    • Clincial Trial Results
    • Recent Concerns
Participants at the IPE meeting in Bogota, Colombia in December 2016.

50. The Development of Heart Failure Care Guidelines to Improve Management in Primary Care

Watch Video

More information

Date: December 19, 2018
Speaker: Alisha Peterson, BSN, RN, CCRN
Panelists:  Alice Chang, MSW, Susan Pambianco, ARNP
Facilitator: Todd Dardas, MD, MS

By the end of this lecture, you should be able to:

  1. Recognize the need to improve heart failure (HF) management at the community level.
  2. Discuss the development of standardized HF care guidelines and workflow.
  3. Identify ways in which HF guidelines could be implemented or improved at your own clinical practice.
Participants at the IPE meeting in Bogota, Colombia in December 2016.

48. Hospital Readmission Reduction: Evidence Against Efficacy

Watch Video

More information

Date: September 19, 2018
Speaker:  Todd Dardas, MD, MS
Panelists:  Susan Pambianco, ARNP; Alice Chang, MSW
Facilitator: Susan Pambianco, ARNP